Prescription drug · ANDA
Tacrolimus NDC 59746-798
Tacrolimus .5 mg/1 · Capsule, Gelatin coated · Oral · Jubilant Cadista Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59746-798-01 | 59746079801 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (59746-798-01)Marketed from Nov 30, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tacrolimus
- Generic name (nonproprietary)
- tacrolimus
- Active ingredients
- Tacrolimus — .5 mg/1
- Dosage form
- Capsule, Gelatin coated
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090802
- Marketing start
- Listing expires
- Other FDA classes
- Calcineurin Inhibitors (Mechanism)
- Identifiers
- Product ID 59746-798_e39f4aa6-bc0f-413d-b855-3bf869c2e2eeSPL ID e39f4aa6-bc0f-413d-b855-3bf869c2e2eeSPL set ID 651bd506-96b0-43e5-a4dd-db03bf9154c9RxCUI 198377, 198378, 313190UNII WM0HAQ4WNM
- Pharmacologic class
- Calcineurin Inhibitor Immunosuppressant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459746079801followed by a unit qualifier and the quantityPackage 59746-0798-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Tacrolimus Capsules USP is a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants, in combination with other immunosuppressants. ( 1.1 ) 1.1 Prophylaxis of Organ Rejection in Kidney, Liver, Heart, or Lung Transplant Tacrolimus Capsules USP is indicated for the prophylaxis of organ rejection, in adult and pediatric patients receiving allogeneic kidney transplant [see Clinical Studies (14.1) ] , liver transplant [see Clinical Studies (14.2) ] , heart transplant [see Clinical Studies (14.3) ] , or lung transplant [see Clinical Studies (14.4) ] in combination with ot…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090802
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tacrolimus | Tacrolimus 1 mg/1 | Capsule, Gelatin coatedOral | Panacea Biotec Limited | 43817-422 |
| Tacrolimus | Tacrolimus .5 mg/1 | Capsule, Gelatin coatedOral | Panacea Biotec Limited | 43817-421 |
| Tacrolimus | Tacrolimus 5 mg/1 | Capsule, Gelatin coatedOral | Panacea Biotec Limited | 43817-423 |
| Tacrolimus | Tacrolimus 1 mg/1 | Capsule, Gelatin coatedOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-799 |
| Tacrolimus | Tacrolimus 5 mg/1 | Capsule, Gelatin coatedOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-800 |